LGND
Ligand Pharmaceuticals Incorporated
Company Overview
| Mkt Cap | $3.56B | Price | $191.31 |
| Volume | 383.18K | Change | +2.27% |
| P/E Ratio | -882.9 | Open | $187.78 |
| Revenue | $167.1M | Prev Close | $187.06 |
| Net Income | $-4.0M | 52W Range | $93.58 - $194.44 |
| Div Yield | N/A | Target | $184.29 |
| Overall | 66 | Value | 40 |
| Quality | 68 | Technical | 90 |
No chart data available
Stock Overview
Updated DailyLigand Pharmaceuticals Incorporated (LGND) is a leading Healthcare company in the Biotechnology industry, currently trading at $191.31 with a market capitalization of $3.56 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating solid quality metrics with a MarketXLS quality score of 68.
Today's trading session shows LGND with a volume of 383K shares. The stock opened up 0.38% from yesterday's close of $187.06. Current analyst estimates project earnings of $0.31 per share for this year, with next year targeting $4.66.
LGND demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including AMGN, SPPI, GSK, MRK, PFE.
Key investment considerations for LGND include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -3.7%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 02:00 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LGND | $191.31 | +2.3% | 383.18K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW